Equity Details
Price & Market Data
Price: $28.80
Daily Change: +$2.35 / 8.16%
Daily Range: $26.41 - $28.80
Market Cap: $1,633,001,728
Daily Volume: 2,978,829
Performance Metrics
1 Week: 13.94%
1 Month: 22.29%
3 Months: -4.21%
6 Months: -10.12%
1 Year: -47.30%
YTD: -8.80%
About PROCEPT BioRobotics Corporation (PRCT)
In-depth market report for PROCEPT BioRobotics Corporation (PRCT). The stock is valued at 28.80, with a daily change of +$2.35 / 8.16%. Market cap: 1,633,001,728. All key performance metrics are updated, including YTD and 52-week returns.
Company Details
Employees: 888
Sector: Health technology
Industry: Medical specialties
Country: United States
Details
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.